Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood from patients with breast cancer in the laboratory may
help doctors identify and learn more about biomarkers related to tamoxifen resistance.
PURPOSE: This laboratory study is looking at tamoxifen resistance in women with stage I,
stage II, stage IIIA, or stage IIIB breast cancer.
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences